Monozygotic dichorionic-diamniotic pregnancies following single frozen-thawed blastocyst transfer: a retrospective case series.

Five thousand four hundred fifteen single blastocyst FET cycles were performed between June 2013 and December 2018 at our infertility center and 2510 (46.4%) resulted in a clinical pregnancy. From the 1510 clinical pregnancies, 43 (2.8%) were monozygotic twinning (MZT) pregnancies. 14 (0.9%) of total pregnancies were monozygotic DC-DA pregnancies which had two gestational sacs on 6–7 gestational weeks` ultrasound examination. 29 (1.9%) of total clinical pregnancies were monozygotic monochorionic pregnancies. Excluding one natural cycle FET, finally we included 13 women who were in down-regulated controlled FET or hormone replacement therapy FET (with FET cycle ultrasound documenting absence of spontaneous ovulation), in which concomitant spontaneous pregnancy could not happen. The incidence rate of monozygotic DC-DA pregnancies was 0.5% (13/2510) after single blastocyst FET. Demographic data about these 13 patients are showed in Table  1 . ART treatment information are showed in Table  2 . Pregnancy outcomes are showed in Table  3 . Demographic and IVF-FET cycle characteristics between monochorionic and dichorionic twining group were comparable, which was showed in Table  4 . All the included thirteen patients had at least one reported risk factors associated with monozygotic twinning, including the procedure of ICSI (9/13), assisted hatching (5/13), and blastocyst transfer (13/13). PGT was performed in 5/13 patients. Figure  1 shows the initial ultrasound confirming dichorionic-diamniotic twinning at 6 to 7 weeks of gestation. Table 1 Demographic characteristics Age (years) BMI (kg/m2) Gravidity Parity Diagnosis Antral follicle count No. of prior IVF attempts No. of prior D3 embryos transferred No. of prior blastocysts transferred Case 1 31 21.23 4 0 Recurrent miscarriage, male reciprocal translocation 27 0 0 0 Case 2 38 24.97 1 0 Tubal factor and male factor 13 2 2 0 Case 3 33 17.97 2 0 Tubal factor 24 0 0 0 Case 4 34 17.19 0 0 Male factor 18 0 0 1 Case 5 41 21.26 3 1 Tubal factor and male factor 13 0 0 0 Case 6 33 19.92 1 1 PCOS and male factor 19 0 4 0 Case 7 28 20.51 0 0 Endometriosis 8 0 0 0 Case 8 39 23.31 3 0 Recurrent miscarriage 18 0 0 1 Case 9 38 19.92 3 0 SNM1 mutation 24 0 0 3 Case 10 30 18.59 0 0 Male robertsonian translocation 16 0 0 0 Case 11 42 22.83 2 1 Unexplained infertility 12 0 0 0 Case 12 43 21.97 2 0 Recurrent miscarriage 8 0 0 1 Case 13 32 25.39 2 1 Tubal factor 29 0 0 0 PCOS polycystic ovarian syndrome, SNM1 survival motor neuron gene Table 2 IVF cycle characteristics COH protocol Gonadotropin injection (units) Days of stimulation # of oocytes retrieved # of blastocysts Fertilization method AH PGT Endometrial preparation Embryo day at transfer Grade of blastocyst at thaw Endometrial thickness in FET (mm) Case 1 Antagonist 975 9 32 3 ICSI Yes Yes HRT D5 B5BC 9 Case 2 Short agonist 3225 12 17 1 ICSI No No HRT D5 B3BB 8 Case 3 Antagonist 750 9 11 4 IVF No No HRT D5 B4BA 10 Case 4 CC + HMG 850 10 21 9 ICSI No No Down-regulated D5 B5BA 9 Case 5 Short agonist 1800 8 14 7 ICSI No No HRT D5 B4AB 8 Case 6 Antagonist 1000 8 18 5 ICSI No No Down-regulated D5 B3CB 9 Case 7 Long agonist 3300 11 7 1 IVF No No Down-regulated D5 B4BB 11 Case 8 CC + HMG 1125 9 9 3 ICSI Yes Yes HRT D5 B5BB 7 Case 9 Antagonist 1450 10 31 16 ICSI Yes Yes Down-regulated D5 B5CB 9 Case 10 Short agonist 1350 9 21 4 ICSI Yes Yes Down-regulated D5 B5BC 11 Case 11 CC + HMG 1800 9 6 3 IVF No No Down-regulated D5 B4BB 11 Case 12 CC + HMG 2250 9 7 3 ICSI Yes Yes Down-regulated D6 B6AB 8 Case 13 Antagonist 1987.5 10 28 5 IVF No No HRT D5 B5BC 7 Table 3 Pregnancy outcomes β-hCG (mIU/mL) # of gestational sacs # of fetal poles Pregnancy outcome Gestation at delivery (weeks + days) Birth weight (g) Gender of newborn(s) Mode of delivery Obstetric complications Neonatal complications Case 1 979 2 2 2 live birth females 38 + 3 2900/3300 Female/Female Elective caesarean Gestational hypertension Case 2 1330 2 2 2 live birth males 36 2250/2360 Male/Male Emergency caesarean Case 3 980 2 2 2 live birth females 39 + 1 3000/3010 Female/Female Elective caesarean Case 4 731 2 2 2 live birth males 31 + 2 1500/1650 Male/Male Emergency caesarean One newborn had necrotizing enterocolitis and cured by surgery. Case 5 606 2 2 vanishing twin, 1 liveborn singleton 38 + 5 3150 Female Elective caesarean Marginal placenta previa Case 6 467 2 2 vanishing twin, 1 liveborn singleton 39 + 3 3150 Female Elective caesarean Case 7 190 2 1 1 liveborn singleton 40 + 4 3850 Male Vaginal delivery Case 8 1367 2 1 1 liveborn singleton 40 + 1 3000 Male Vaginal delivery GDM Case 9 1370 2 1 1 liveborn singleton 38 + 5 3350 Male Elective caesarean Case 10 582 2 1 1 liveborn singleton 39 3000 Male Elective caesarean Gestational hypertension Case 11 1370 2 1 1 liveborn singleton 39 3080 Male Elective caesarean Case 12 1289 2 1 1 liveborn singleton 38 3000 Female Elective caesarean GDM Case 13 2055 2 1 1 liveborn singleton 36 + 3 3150 Male Vaginal delivery GDM gestational diabetes mellitus Table 4 Demographic and IVF-FET cycle characteristics in monochorionic and dichorionic twining group Monochorionic Dichorionic P -value ( n  = 29) ( n  = 14) Age at IVF (years) 34.7 ± 4.5 35.4 ± 4.7 0.674 Body mass index (kg/m 2 ) 22.4 ± 3.8 21.2 ± 2.4 0.301 Primary infertility 12 (41.4) 5 (35.7) 0.722 Fertilization method  Conventional IVF 12 (41.4) 5 (35.7) 0.722  ICSI 17 (58.6) 9 (64.3) Assisted hatching  No 16 (55.2) 8 (57.1) 0.903  Yes 13 (44.8) 6 (42.9) PGT  No 17 (58.6) 8 (57.1) 0.927  Yes 12 (41.4) 6 (42.9) Embryo day at transfer  Day 5 23 (79.3) 12 (85.7) 0.613  Day 6 6 (20.7) 2 (14.3) Endometrial preparation  Natural cycle 2 (6.9) 1 (7.1) 0.976  HRT or down-regulated 27 (93.1) 13 (92.9) Endometrial thickness in FET (mm) 9.0 ± 1.1 8.9 ± 1.4 0.856 Data presented as mean ± SD or n (%) Fig. 1 The images of the initial ultrasound at gestational 6–7 weeks. Case 1 to 6: gestational 6–7 weeks` ultrasound with 2 gestational sacs and 2 fetal poles. Case 7 to 13: gestational 6–7 weeks` ultrasound with 2 gestational sacs and 1 fetal pole Demographic characteristics PCOS polycystic ovarian syndrome, SNM1 survival motor neuron gene IVF cycle characteristics Pregnancy outcomes vanishing twin, 1 liveborn singleton vanishing twin, 1 liveborn singleton GDM gestational diabetes mellitus Demographic and IVF-FET cycle characteristics in monochorionic and dichorionic twining group Data presented as mean ± SD or n (%) The images of the initial ultrasound at gestational 6–7 weeks. Case 1 to 6: gestational 6–7 weeks` ultrasound with 2 gestational sacs and 2 fetal poles. Case 7 to 13: gestational 6–7 weeks` ultrasound with 2 gestational sacs and 1 fetal pole

We retrospectively reviewed all frozen thawed single blastocyst transfer cycles performed between Jan 2013 and December 2018 at the Shanghai JiAi Genetics & IVF Institute. This study was approved by the Ethics Committee of Assisted Reproductive Medicine in Shanghai JiAi Genetics & IVF Institute (JIAI E2020–02). FET cycles were analyzed when clinical pregnancy was confirmed alone with one or more gestational sacs showed on ultrasonography at around 6 to 7 weeks of gestation. We further identified all patients with two or more gestational sacs noted on initial ultrasound, suggesting possible multi-chorionic monozygotic pregnancies. We then conducted an in-depth analysis to further exclude cases which contained newborns of different sexes or natural FET cycles, in order to rule out the possibility of dizygosity. Demographic data and IVF treatment information including obstetrical and neonatal outcome data of the included cases were summarized and analyzed. Moreover, we compared the demographic and IVF-FET cycle characteristics between monochorionic and dichorionic twining group. Comparison of quantitative variables were performed using Student’s t-test, while categorical variables were compared using a χ2 analysis. All statistical analyses of the data were performed using the SPSS program V.21.0 (SPSS), and a P value < 0.05 was considered statistically significant. Women underwent IVF, ICSI or preimplantation genetic testing (PGT) treatment in the center according to clinical indications. Protocols of controlled ovarian stimulation included: gonadotropin-releasing hormone (GnRH) antagonist protocol, short or long GnRH agonist protocol, and clomiphene citrate (CC) + human menopausal gonadotropin (hMG) or follicle-stimulating hormone (FSH) protocol. Oocyte retrieval was performed 34-36 h after human chorionic gonadotropin (hCG) or GnRH agonist trigger under transvaginal ultrasound guidance. Obtained oocytes were fertilized using either conventional IVF or ICSI as clinically indicated, and incubated in fertilization media (Vitrolife, Sweden). Fertilization was judged by the appearance of two pronuclei and a second polar body at 16–18 h after IVF or ICSI. Fertilized zygotes were grown to the blastocyst stage in sequential culture media (G1 and G2, Vitrolife). Assisted hatching was performed on D3 embryo with an 18 μm hole made in the zona pellucida of the embryos. PGT biopsy was performed on day 5 or day 6 embryo. Approximately 3–5 trophectoderm cells were biopsied using a pipette and placed into polymerase chain reaction (PCR) tubes. Then the cells were either directly used for Whole genome amplification (WGA) or cryopreservation for later WGA. All the testing experiments and data analysis were completed in Ji Ai local genetic laboratory. Endometrial preparation for FET was achieved by either hormone replacement treatment (HRT) or down-regulated HRT-FET. For HRT-FET, on day 3 of the menstrual cycle, estradiol valerate (E2, Progynova, Schering AG, Berlin, Germany) was commenced 4 mg daily for 10–12 days. When the thickness of the endometrium reaches at least 7 mm on pelvic ultrasound scanning, progesterone in oil (80 mg) was added. Ultrasound was performed not only to evaluate endometrial lining, but also to confirm no dominant follicles in bilateral ovaries. For down-regulated FET, GnRH agonist was usually given in the mid luteal phase (day 21) of the menstrual cycle. Pituitary down-regulation was confirmed on the second or third day of the expected next menstruation. If baseline levels have been reached and the ovaries are quiescent on pelvic scanning, HRT with estradiol valerate was started as described above. Blastocyst transfer was scheduled on the sixth day of starting intramuscular progesterone. Single blastocyst with the best morphology was transferred under transabdominal ultrasound guidance using a soft catheter. After thawing, embryo score was assessed according to Gardner morphological criteria [ 11 ], on the basis of the degree of expansion and the development of the inner cell mass and trophectoderm. Serum hCG level was checked 14 days after FET. All hormone therapy was stopped if the serum hCG level was negative. Pregnant women continued the hormonal therapy until 12 weeks of gestation.

When a single embryo divides into two after fertilization defines the type of twin pregnancy. There is a classical theory presented by Corner about the timing of embryo division and twin pregnancy development: within 3 days of fertilization, dichorionic-diamniotic (DC-DA) twins; between 4 and 8 days, monochorionic-diamniotic (MC-DA) twins; and between 9 and 12 days, monochorionic-monoamniotic (MC-MA) twins; and rarely, after 12 days, conjoined twins [ 1 , 2 ]. Assisted reproductive technology (ART) has been associated with multiple gestations as a result of transfer with more than one embryos, which may develop into DC-DA twins. However, the frequency of monozygotic twinning after ART also increases, which varies from 0 to 13.2% compared with 0.4% of live births in spontaneous conception population [ 3 , 4 ]. Although the specific mechanism of the increased risk of monozygotic twinning with in vitro fertilization (IVF) is controversial, researchers have proposed a lot of risk factors including extended embryo culture, female age and certain IVF procedures, especially those related to micromanipulation of the zona pellucida as intracytoplasmic sperm injection (ICSI) or assisted hatching (AH), embryo biopsy and embryo cryopreservation [ 3 – 8 ]. The information on monozygotic DC-DA twinning after single blastocyst transfer is extremely limited. As it differs with the deep-rooted multiple pregnancy theory that single blastocyst transfer should only lead to MC-DA or MC-MA twinning, more studies and further investigation are needed. Many DC-DA twinning are suspected to be the results of either transfer of more than one embryo or less common, spontaneous pregnancies at the same time [ 9 ]. DC-DA monozygotic twinning rate is underestimated because genetic testing of offspring is rarely performed [ 10 ]. Therefore, we collected and analyzed data of thirteen cases of monozygotic DC-DA twinning after single blastocyst transfer in down-regulated or hormone replacement frozen embryo transfer (FET) cycles.

In conclusion, we reviewed 13 cases found among 5415 single blastocyst FET cycles resulted in a monozygotic DC-DA gestation. This is the largest case series showed that single blastocyst transfer could result monozygotic DC-DA pregnancies during IVF treatment which challenged the accepted theory. Patients should be informed of a possible increased risk of monozygotic multiple pregnancies after single blastocyst FET. The frequency and mechanism of how the monozygotic multichorionic pregnancy occurs after single blastocyst transfer is still unknown. Further studies are needed to clarify the mechanism of monozygotic splitting, especially the effects of IVF treatment on early embryo development.

Since the first case of monozygotic twinning associated with IVF was reported in 1984 [ 12 ], the incidence of MZT following assisted reproduction has been continually rising [ 13 ]. The development model of monozygotic twinning was described by Corner for the first time in 1955 and has become accepted as golden rule, which is now often published in textbooks and literature. A monozygotic DC-DA twining is assumed to develop when a cleavage embryo splits within the first 3 days after fertilization, before the inner cell mass cells differentiate [ 14 ]. As Herranz writes, the theory was quickly accepted due to Corner’s prestige, the internal logic of the model, and the convincing nature of his graphic depiction [ 15 ]. The universally accepted idea about the various modes of monozygotic twinning (addressed as `the mode`) is based on few experimental data, because embryo experimentation must meet restrictions in humans [ 16 ]. However, our study reported 13 single blastocyst FET cases resulted monozygotic DC-DA twinning, which challenged the golden rule. In our retrospective study examining a large cohort of single blastocyst FETs, we report a 2.8% MZT pregnancy rate following single blastocyst FET, comparable to previous studies [ 5 , 6 ]. Most of the MZT pregnancies were monochorionic, similar to the previous report [ 6 ]. The incidence rate of monozygotic DC-DA pregnancies was 0.5% (13/2510) after single blastocyst FET in our study. Most previous studies of single blastocyst transfer resulted in DC-DA twins are case reports. A recent study reported four cases of single blastocyst transfer resulted in monozygotic DC-DA twins in down-regulated controlled FET cycles, the incidence rate of monozygotic DC-DA pregnancies was 0.3% (4/1181) after single blastocyst FET [ 17 ], which was comparable with our study. Other case reports stated atypical hatching would lead to monozygotic twinning after single blastocyst transfer [ 2 , 18 , 19 ]. Another research including 4976 clinical gestations showed that they had never observed an embryo division in half before the blastocyst stage during over 15 years of IVF treatment and laboratory experience [ 14 ]. Alone with our findings, the popular credo of chorionicity simply based upon the day of embryonic development must be reevaluated. Moreover, there must be an underestimation of the rate of monozygotic DC-DA twins associated with IVF treatment, because monozygotic multiple pregnancies may not be noticed if more than one embryo are transferred. Since all the published studies are retrospective or case reports with small sample sizes and lack of fetal or neonatal genetic analyses, which makes it difficult to draw concrete conclusions against the long believed dogma and needs further research. The mechanism of monozygotic division is still unknown. Micromanipulation of the zona pellucida during ICSI, embryo biopsy, and assisted hatching has been reported to be risk factors associated with monozygotic pregnancy during IVF treatment in a lot of studies [ 9 , 19 , 20 ]. According to the most popular theory, AH might increase the incidence of the inner cell mass split and two fetal plates consequently develop [ 19 ]. While some other studies show opposite results, that embryo manipulation (ICSI, assisted hatching, embryo biopsy) do not increase the risk of monozygotic pregnancies [ 9 , 21 ]. In our 13 cases, possible previously reported risk factors related to the incidence of monozygotic multiple pregnancy were embryo biopsy for PGT, AH, ICSI and extended culture. Both AH and embryo biopsy were performed in 5 of the 13 cases; ICSI was done in 9 of the 13 cases in the study. Single blastocyst transfer is recommended in many countries as it has a favorable prognosis for live-birth as well as low multiple pregnancy. But extended culture may play a role in the development of MZT. Transferring embryos at blastocyst stage exposes the embryo to extra time in the in-vitro environment and may have some effects on the embryo and therefore increase the chance of embryo division. A retrospective analysis showed a 5.6% MZT pregnancy rate in the blastocyst transfer group compared with 2% in the cleavage embryo group [ 22 ]. The mechanism is speculated to be long exposure to low levels of calcium might harm the Intracellular stabilization and consequently lead to the division of the inner cell mass [ 3 , 19 ]. Our study showed a 2.8% MZT pregnancy rate following single blastocyst FET, which was lower than the above study. While another study showed no increase in multiple pregnancies relative to the embryo stage in either the DC-DA or MC-DA twinning [ 23 ]. Risk factors for embryo division remain controversial and more researches are needed to answer the question. A strength of our study is that it includes only down-regulated and HRT single frozen blastocyst transfer, with ultrasound confirming no ovulation during endometrial preparation in FET cycle to rule out the possibility of dizygotic DC-DA twinning. To the best of our knowledge, this is the largest case series about monozygotic multichorionic twining after single blastocyst transfer. One limitation of our study is that monozygosity was not verified by the genetic analysis of the offspring, which is thought to be the gold standard. Therefore, in the future study, we should pay more attention to confirm monozygosity with genetic analysis which is very important and should not be neglected. Another limitation is that we do not routinely take pictures of the transferred embryo on the FET day, so we lack the data of the 13 transferred blastocysts of our included cases.